[Other] Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial |
|
This post will be closed automatically in 2026-06-26 10:43
Reward10points
|
| |
20
Management of fecal incontinence
20
Emergency Department Triage of the “Incessantly Crying” Baby
20
Mummy, me and her podcast: Family and gender discourses in contemporary podcast culture: Not by Accident as audio(auto) biography
50
Studies on taste masking of Drotaverine hydrochloride and its formulation
20
A Change of Pace: A Latent Profile Analysis of Pacing Styles at Work
